Cart summary

You have no items in your shopping cart.

KRN-633

SKU: orb1301043

Description

KRN-633 is a potent small molecule inhibitor targeting vascular endothelial growth factor receptors (VEGFRs), with IC50 values of 170 nM for VEGFR1, 160 nM for VEGFR2, and 125 nM for VEGFR3. It is widely used in preclinical research to study angiogenesis and tumor growth in both cellular assays and animal models.

Research Area

Cardiovascular Research, Signal Transduction

Images & Validation

Key Properties

CAS Number286370-15-8
MW416.86
Purity99.73% (May vary between batches)
FormulaC20H21ClN4O4
SMILESCCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl
TargetVEGFR
SolubilityDMSO:6 mg/mL (14.39 mM)

Bioactivity

Target IC50
VEGFR1:170 nM|VEGFR2:160 nM|VEGFR3:125 nM
In Vivo
In athymic mouse and rat xenograft models, KRN-633 was able to inhibit tumor growth in various tissue sources such as lungs, colon, and prostate. It was also observed that in the non-necrosis region of tumor grafts, the number of endothelial cells was reduced and vascular permeability decreased. In the regenerated tumors, KRN-633 can also ablate tumor growth.
In Vitro
In human umbilical vein endothelial cells, KRN-633 inhibits tyrosine phosphorylation of VEGFR-1, VEGFR2, c-Kit, and PDGFR-β with IC50 of 11.7, 1.16, 8.01, 130 nM, respectively. In endothelial cells, KRN-633 inhibits the formation of the capillary tube. KRN-633 suppress the VEGF-driven proliferation of HUVECs (IC50=14.9 nM).
Cell Research
Cancer cells, such as A549, Ls174T, HT29, DU145, LNCap, and PC-3 cells, are cultured for 24 hours, then add KRN-633 (0.01 to 10 μM)that is prepared in 0.1% DMSO in the medium growing for 96 hours.
Animal Research
In tumor xenografts mice model, are treated with KRN-633(10-100 mg/kg) once or twice per day. In human tumor xenografts athymic rats (BALB/cA, Jcl-nu), when the tumors reach the average size indicated (162 to 657 mm3), and are treated with KRN-633 either once or twice per day. After 14days treatment, Calculate the tumor growth inhibition.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Inhibitor, KRN 633, KRN633, KRN-633, inhibit, VEGFR1, VEGFR, VEGFR3, VEGFR2, Vascular endothelial growth factor receptor

Similar Products

  • KRN-633 [orb1222415]

    >98% (HPLC)

    286370-15-8

    416.86

    C20H21ClN4O4

    1 g, 2 mg, 25 mg, 10 mg, 5 mg, 100 mg, 500 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

KRN-633 (orb1301043)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 ml x 10 mM (in DMSO)
$ 90.00
5 mg
$ 90.00
10 mg
$ 110.00
25 mg
$ 150.00
50 mg
$ 200.00
100 mg
$ 270.00
200 mg
$ 370.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry